Access our insights, latest research, leadership trends and more through our Knowledge Center.
The rising generation of life sciences executives in Denmark, Norway, and Sweden will take the helm at a time of great opportunity and even greater challenges for the industry. Will they be up to the job?
Big pharma faces an ever more complicated and high-stakes regulatory environment. Players that can’t develop new capabilities and mind-sets risk being left behind.
US biotech firms are moving into Europe for all the right reasons—but in some predictably wrong ways. By getting the talent dimensions right up front, they can increase their odds of success.
Given current and future trends, the demand is likely to rise significantly in the coming years for the formidable competencies that healthcare leaders possess—and the talent pool is deep.
Four trends emerging from the 2016 JP Morgan Healthcare Conference highlight the accelerating pace of change and increased emphasis on performance throughout the industry.
This paper highlights the key priorities of medical technology companies in Europe and discusses the dynamics of doing business in the postcrisis environment.